Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 8-K Event Material agreement · Results of operations · Unregistered share sale
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 8-K Event Material agreement
  5. 8-K Event Shareholder vote results
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 8-K Event Regulation FD disclosure
  14. SC 13G Stake Amended Statement of Ownership
  15. 4 Insider Changes in Ownership
  16. EFFECT Other Notice of Effectiveness
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. 4 Insider Changes in Ownership

Page 31 of 39 · 778 filings